Cover Image
Market Research Report
Product code
1017586

Remote Patient Monitoring System Market: Current Analysis and Forecast (2021-2027)

Published: | UnivDatos Market Insights Pvt Ltd | 186 Pages | Delivery time: 1-2 business days

Price

Back to Top
Remote Patient Monitoring System Market: Current Analysis and Forecast (2021-2027)
Published: June 1, 2021
UnivDatos Market Insights Pvt Ltd
Content info: 186 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The remote patient monitoring system is a subclass of telehealth that is designed to deliver healthcare services at the distance. These are typically medical devices deployed at home that transmits vital signs through a data hub, or a desktop console. The data is stored via server-side systems which is then eventually retrieved by caregivers and providers

The remote patient monitoring system focuses on the management of various chronic diseases and infectious diseases. They support patient's healthcare journey and provide patient's health data to clinicians and caregivers enabling them to personalize their treatment and meet all the patient's needs to avoid any complications. In addition to this, it also enables patients to take control of their care alongside the physicians and caregivers

The rising worldwide demand for remote patient monitoring systems is because of the changing traditional medical protocols and rising investments in telehealth solutions. The increased focus on preventive healthcare, technological advancement in remote healthcare, and the need to reduce surging medical costs are some factors driving the growth of remote patient monitoring systems across the world. Another factor contributing towards the growth of this market is the rising chronic diseases incidences and growing ageing population. In addition to this, the worldwide adoption of virtual and home health technologies owing to the number of canceled appointments and deferred care amidst the novel coronavirus outbreak has further augmented the worldwide demand for remote patient monitoring systems

However, some of the restraints in the market include a lack of awareness and regulatory variations across countries. In addition to this, healthcare fraud and resistance from the conventional healthcare system are impeding the growth of this market all over the world

Based on product, the market is divided into vital sign monitors and specialized monitors. The vital sign monitors are further segmented into temperature monitor, blood pressure monitor, pulse oximeter, heart rate monitor, respiratory rate monitor and brain monitor. In contrast, specialized monitors is sub-segmented into blood glucose monitor, cardiac rhythm monitor, anesthesia monitor, respiratory monitor, fetal heart monitor, multiparameter monitor and others

The specialized monitors segment accounted for the major market share owing to their ability to monitor vital parameters that helps in managing various chronic diseases. However, the vital sign monitors segment is anticipated to grow substantially in the projected timeframe

The application segment is fragmented into diabetes, cardiovascular diseases, sleep disorders, weight management & fitness tracking and other applications. The diabetes segment dominated the market owing to the growing prevalence of diabetic population all over the world. However, cardiovascular diseases accounted for second highest market share

Based on end-user, the remote patient monitoring system market is divided into Hospitals/clinics, home care settings and others. The hospitals/clinics segment held the major market share. Apart from this, home care settings segment is also expected to grow significantly in the forthcoming years

For a better understanding of the market adoption of Remote Patient Monitoring System , the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India and Rest of APAC), and Rest of World. North America constitutes the largest market for the remote patient monitoring system industry and generated revenue of USD XX million in 2020 owing to the government support for advanced research and development in the field of telehealth and increasing awareness regarding the benefits offered by them. However, the Asia-Pacific region is also expected to grow at the highest CAGR during the forecast period

Some of the major players operating in the market include F. Hoffmann-La Roche, Medtronic, GE Healthcare, Abbott Laboratories, Omron Corporation, Johnson & Johnson, American Telecare, Philips Healthcare, Boston Scientific Corporation, Biotelemetry, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions

Table of Contents
Product Code: UMHE21242

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Remote Patient Monitoring System Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Global Remote Patient Monitoring System Market
    • 2.1.1 Main Objective of the Global Remote Patient Monitoring System Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPS UNDER REMOTE PATIENT MONITORING SYSTEM SECTOR

6 REMOTE PATIENT MONITORING SYSTEM AMID COVID-19

7 GLOBAL REMOTE PATIENT MONITORING SYSTEM MARKET REVENUE (USD BN), 2021-2027F

8 MARKET INSIGHTS BY PRODUCT

  • 8.1 Vital Sign Monitors
    • 8.1.1 Temperature Monitor
    • 8.1.2 Blood Pressure Monitor
    • 8.1.3 Pulse Oximeters
    • 8.1.4 Heart Rate Monitor (ECG)
    • 8.1.5 Respiratory Rate Monitor
    • 8.1.6 Brain Monitor (EEG)
  • 8.2 Specialized Monitors
    • 8.2.1 Blood Glucose Monitor
    • 8.2.2 Cardiac Rhythm Monitor
    • 8.2.3 Anesthesia Monitor
    • 8.2.4 Respiratory Monitor
    • 8.2.5 Fetal Heart Monitor
    • 8.2.6 Multiparameter Monitor
    • 8.2.7 Others

9 MARKET INSIGHTS BY APPLICATION

  • 9.1 Diabetes
  • 9.2 Cardiovascular Diseases
  • 9.3 Sleep Disorders
  • 9.4 Weight Management & Fitness Tracking
  • 9.5 Other Applications

10 MARKET INSIGHTS BY END-USER

  • 10.1 Hospitals/Clinics
  • 10.2 Home Care Settings
  • 10.3 Others

11 MARKET INSIGHTS BY REGION

  • 11.1 North America Remote Patient Monitoring System Market
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Rest of North America
  • 11.2 Europe Remote Patient Monitoring System Market
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 United Kingdom
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Rest of Europe
  • 11.3 Asia Pacific Remote Patient Monitoring System Market
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 Rest of Asia Pacific
  • 11.4 Rest of World Remote Patient Monitoring System Market

12 REMOTE PATIENT MONITORING SYSTEM MARKET DYNAMICS

  • 12.1 Market Drivers
  • 12.2 Market Challenges
  • 12.3 Impact Analysis

13 REMOTE PATIENT MONITORING SYSTEM MARKET OPPORTUNITIES

14 REMOTE PATIENT MONITORING SYSTEM MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

  • 16.1 Demand Side Analysis
  • 16.2 Supply Side Analysis
    • 16.2.1 Top Product Launches
    • 16.2.2 Top Business Partnerships
    • 16.2.3 Top Business Expansions, Investments and Divestitures
    • 16.2.4 Top Merger and Acquisitions

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

  • 18.1 Porter's Five Forces Analysis
    • 18.1.1 Bargaining power of Supplier
    • 18.1.2 Bargaining power of Buyer
    • 18.1.3 Industry Rivalry
    • 18.1.4 Availability of Substitute
    • 18.1.5 Threat of new Entrants
  • 18.2 Competitive Landscape
    • 18.2.1 Company Shares, By Revenue

19 COMPANY PROFILED

  • 19.1 Medtronic
  • 19.2 F Hoffmann-La Roche
  • 19.3 GE Healthcare
  • 19.4 Abbott Laboratories
  • 19.5 Omron Corporation
  • 19.6 Johnson & Johnson
  • 19.7 American Telecare
  • 19.8 Philips Healthcare
  • 19.9 Boston Scientific Corporation
  • 19.10 Biotelemetry, Inc.

20 DISCLAIMER